Germany· DE-A57-f1da81c2b109d95c
Lavendelöl
A medicinal product containing lavandulae aetheroleum 10 %, registered in Germany by Weleda Ag.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Lavandulae Aetheroleum 10 %
- Manufacturer
- Weleda Ag
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lavandulae aetheroleum 10 % in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomKalms Lavender One-A-Day 80mg capsulesG.R. Lane Health Products Ltd
- CzechiaLAVEKANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
- SwitzerlandLaitea
- SpainLASEA 80 MG CAPSULAS BLANDASDr. Willmar Schwabe Gmbh & Co. Kg
- FranceHUILE ESSENTIELLE DE LAVANDE SCHWABE, capsule molleWILLMAR SCHWABE
- Japanラベンダー油
- PolandLawenolPoznańskie Zakłady Zielarskie "Herbapol" S.A.
- SwedenLavender oil Medipha Kapsel, mjukMEDIPHA SANTE
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Lasea
- Belgium · Laseaxan
- Bulgaria · Лавандулов Спирт Химакс Фарма, Леваксан
- Czechia · Lavekan
- Estonia · Lilandor
- Spain · Lasea
- France · Huile Essentielle De Lavande, Huile Essentielle De Lavande Medipha
- United Kingdom (Northern Ireland) · Kalms Lavender One-A-Day
- Greece · Relandel
- Italy · Laila
- Lithuania · Lilandor
- Latvia · Lilandor
- Netherlands · Laseaxan
- Poland · Lawenol
- Portugal · Serlieve
- Romania · Lilandor
- Sweden · Lasea, Lavancap
- Slovakia · Lavekan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7075abc5-581f-4c52-adf5-9ac46c1b7c96 GET /v1/drugs/7075abc5-581f-4c52-adf5-9ac46c1b7c96?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Lavandulae Aetheroleum 10 %",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about lavandulae aetheroleum 10 %.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.